Topics

A method of tracking where compounds of interest travel and where they are retained in the organs and tissues of an experimental animal or human subject receiving a vaccine; the biodistribution of a vaccine.

vaccines
‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
2.4 Nonclinical Overview AZD1222
2.5 Clinical Overview: AZD1222 Marketing Authorisation Application - Primary Analysis (Data Cut-off 07 December 2020)
Assessment report: COVID-19 Vaccine Moderna
Autoimmune inflammatory reactions triggered by the COVID-19 genetic vaccines in terminally differentiated tissues
Barrier Capacity of Human Placenta for Nanosized Materials
COVID-19 vaccines – An Australian Review
Detection of antibodies to SARS-CoV-2 after vaccination in seminal plasma and their association to sperm parameters
Differences in Vaccine and SARS-CoV-2 Replication Derived mRNA: Implications for Cell Biology and Future Disease
Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients
First case of postmortem study in a patient vaccinated against SARS-CoV-2
Inadvertent Exposure to Pharmacologically Designed Lipid Nanoparticles Via Bodily Fluids: Biologic Plausibility and Potential Consequences
Nonclinical Evaluation Report: BNT162b2 [mRNA] COVID-19 vaccine (COMIRNATY)
Potential adverse effects of nanoparticles on the reproductive system
Rapid Response to: Will covid-19 vaccines save lives? Current trials aren’t designed to tell us
Research Letter: Detection of Messenger RNA COVID-19 Vaccines in Human Breast Milk
SARS-CoV-2 Spike Protein Accumulation in the Skull-Meninges-Brain Axis: Potential Implications for Long-Term Neurological Complications in post-COVID-19
Spike Proteins of SARS-CoV-2 Induce Pathological Changes in Molecular Delivery and Metabolic Function in the Brain Endothelial Cells
Statement by Dr. Richard Urso
Strategies for the Management of Spike Protein-Related Pathology
The Pfizer Papers: Pfizer's Crimes Against Humanity
Understanding the Pharmacology of COVID-19 mRNA Vaccines: Playing Dice with the Spike?
Urgent Open Letter from Doctors and Scientists to the European Medicines Agency regarding COVID-19 Vaccine Safety Concerns
Vaccine mRNA Can Be Detected in Blood at 15 Days Post-Vaccination
551